Internal Medicine, Hematology & Oncology · Orange City, FL
NPI
1598733685
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1061 Medical Center Dr Ste 110
Orange City, FL, 32763
Phone (386) 917-7594
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
1,172 services
Medicare patients, 2024
141
Average age 76
Drug cost, 2024
$4.4M
842 prescriptions
Company payments, 2025
$113
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mamta V Vijayvargiya was code 36415 (venipuncture blood collection), 144 times for 63 patients. In total Mamta V Vijayvargiya billed 1,172 services in 37 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 144 | 63 | $8.65 | $1,246 |
| 85025 Blood Count | Office | 136 | 64 | $7.61 | $1,035 |
| 99214 Office E&M - Established | Office | 124 | 98 | $70.32 | $8,720 |
| 99223 Hospital E&M - Initial | Facility | 19 | 16 | $127.33 | $2,419 |
| 99204 Office E&M - New | Office | 17 | 17 | $99.31 | $1,688 |
| 99213 Office E&M - Established | Office | 17 | 16 | $48.08 | $817 |
| 80053 Clinical Chemistry | Office | 14 | 13 | $10.35 | $145 |
By year: 2022 $120K for 11,909 services; 2023 $81K for 11,008 services; 2024 $40K for 1,172 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 144 | 63 | $8.65 | $1,246 |
| 85025 Blood Count | 136 | 64 | $7.61 | $1,035 |
| 80053 Clinical Chemistry | 14 | 13 | $10.35 | $145 |
Medicare prescription drug claims, 2024
In 2024, the drug Mamta V Vijayvargiya prescribed most often to Medicare patients was Anastrozole, with 219 prescriptions and refills. In total Mamta V Vijayvargiya wrote 842 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 219 | 459 | 52 | $3,480 |
| Revlimid Lenalidomide | 70 | 70 | Under 11 | $970K |
| Hydroxyurea Generic | 42 | 68 | 11 | $741 |
| Prolia Denosumab | 37 | 219 | 22 | $64K |
| Xgeva Denosumab | 36 | 36 | Under 11 | $113K |
| Ibrance Palbociclib | 31 | 31 | Under 11 | $505K |
| Dexamethasone Generic | 25 | 27 | Under 11 | $469 |
| Reblozyl Luspatercept-Aamt | 23 | 23 | Under 11 | $306K |
| Pomalyst Pomalidomide | 22 | 22 | Under 11 | $436K |
| Procrit Epoetin Alfa | 21 | 21 | Under 11 | $84K |
| Lupron Depot Leuprolide Acetate | 15 | 25 | Under 11 | $45K |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 14 | 14 | Under 11 | $245K |
| Tamoxifen Citrate Generic | 14 | 40 | Under 11 | $397 |
| Jakafi Ruxolitinib Phosphate | 13 | 13 | Under 11 | $231K |
| Venclexta Venetoclax | 12 | 12 | Under 11 | $118K |
Brand drugs: 421 claims; generic drugs: 421 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mamta V Vijayvargiya $113 ($113 in general payments such as food, travel and fees) from 5 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $27.58.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.